In another study by M.V. Vander Heiden’s group, the authors argued that since PKM2 is not required for the growth of several cancers, as demonstrated by earlier studies, loss-of-function mutations observed in some human tumors are not oncogenic but rather help to create a metabolic state that favors the proliferation of tumor cells [33]. This evidence concerns the gene PKM and neoplasm.